FMO4 | Flavin containing monooxygenase 4 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FOXI2 | Forkhead box I2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FREM2 | FRAS1 related extracellular matrix protein 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FUT6 | Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
FXYD6-FXYD2 | FXYD6-FXYD2 readthrough | Predicted membrane proteins
| | | | | Tissue enhanced |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GLIS1 | GLIS family zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
GPR113 | G protein-coupled receptor 113 | G-protein coupled receptors Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRB14 | Growth factor receptor-bound protein 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HAVCR1 | Hepatitis A virus cellular receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HGD | Homogentisate 1,2-dioxygenase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOGA1 | 4-hydroxy-2-oxoglutarate aldolase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HOXA9 | Homeobox A9 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXB6 | Homeobox B6 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXB8 | Homeobox B8 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXC10 | Homeobox C10 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXD11 | Homeobox D11 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXD8 | Homeobox D8 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HPN | Hepsin | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HSD17B14 | Hydroxysteroid (17-beta) dehydrogenase 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
IL17RB | Interleukin 17 receptor B | Predicted membrane proteins
| | | | | Tissue enhanced |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCP | Kielin/chordin-like protein | Predicted secreted proteins
| | | | | Tissue enhanced |
KIF12 | Kinesin family member 12 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KMO | Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LGSN | Lengsin, lens protein with glutamine synthetase domain | Predicted intracellular proteins
| | | | | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
LYG1 | Lysozyme G-like 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
MEI4 | Meiosis-specific 4 homolog (S. cerevisiae) | Predicted secreted proteins
| | | | | Tissue enhanced |
MFSD4 | Major facilitator superfamily domain containing 4 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMP24 | Matrix metallopeptidase 24 (membrane-inserted) | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
MRO | Maestro | Predicted intracellular proteins
| | | | | Tissue enhanced |
MT1G | Metallothionein 1G | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MT1HL1 | Metallothionein 1H-like 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
MTNR1A | Melatonin receptor 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MYO3B | Myosin IIIB | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |